TABLE 1.
Author and Year | Cohort | No. Patients Included (N) | Length of Follow-Up (Years) | Risk Factors |
---|---|---|---|---|
Bernhardt et al. 2011 | Germany, Study of Health in Pomerania | 3134 | 5 | Palpation pain in the TMJ |
Dawes et al. 2020 | UK, UK Biobank | 3177 | 4 | None identified |
Dille et al. 2010 | USA, Veterans Affairs Rehabilitation Research and Development Service | Case control study, cisplatin N = 98; carboplatin N = 38; controls N = 57 | Cisplatin, carboplatin | |
Glicksman et al. 2014 | Nurses’ Health Study II | 65085 | 18 | Caffeine intake (protective) |
Gopinath et al. 2010 | Australia, Blue Mountains Hearing Study | 1214 | 5 | Lower age, hearing loss, reported history of whiplash, symptomatic dizziness |
Hwang et al. 2018 | Taiwan, Longitudinal Health Insurance Database | Case control study, with migraine N=1056; without migraine N=4224 | 6 | Migraine |
Lee et al. 2016 | Taiwan, Longitudinal Health Insurance Database | Case control study, with TMJ disorder N=362, without TMJ disorder N=530 | 6 | TMJ disorder |
Nondahl et al. 2002 | USA, Epidemiology of Hearing Loss Study | 2513 | 5 | Hearing loss, total cholesterol, history of head injury, otosclerosis |
Nondahl et al. 2010 | USA, Epidemiology of Hearing Loss Study | 2922 | 10 | History of arthritis, history of head injury, history of ever smoking, among women hearing loss, moderate alcohol consumption (protective), lower age among women, obesity among men (protective) |
Shih et al. 2017 | Taiwan, Longitudinal Health Insurance Database | Case control study, with CKD N=185430; without CKD N=566290 | 10 | CKD |
CKD, chronic kidney disease; TMJ, temporomandibular joint.